A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps

Clinical trial NCT02912468 · COMPLETED

Trial details

NCT number: NCT02912468
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Start date: 2016-12-05
Primary completion: 2018-07-05
Enrollment: 276

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.